The Oslo Chronic Fatigue Consortium (OCFC) brings together more than 100 clinicians and researchers from Norway, the wider ...

Patients suffering from long COVID may exhibit persistent inflammation in the heart and lungs for up to a year following SARS ...

Many patients suffer not only from respiratory symptoms due to their COVID-19 disease, but also from significantly reduced ...

Researchers at the University of Alabama at Birmingham (UAB) have identified what is believed to be the first intervention found in a randomized controlled trial to show large and very large ...

Patients suffering from long COVID may exhibit persistent inflammation in the heart and lungs for up to a year following SARS ...

Jasmine Laws is a US News Reporter at Newsweek based in London, U.K. Her focus is reporting on health insurance, including Medicare and Medicaid, but she also writes about U.S. politics, crime and ...

Patients suffering from long COVID may exhibit persistent inflammation in the heart and lungs for up to a year following SARS-CoV-2 infection-even when standard medical tests return normal ...

The findings of the study published in journal PLOS One showed that obesity was significantly associated with a persistent ...

Patients suffering from long COVID may exhibit persistent inflammation in the heart and lungs for up to a year following SARS ...

Nigel McCracken, chief operating officer, Virax Biolabs, discusses new findings that reveal altered cytokine activity and evidence of T cell exhaustion in long COVID patients, providing deeper insight ...

Patients suffering from long ... long COVID cohort. “We found a range of cardiopulmonary inflammatory patterns, backed by abnormal protein profiles,” Dr. Trivieri says. “These insights ...

Placebo-controlled clinical trial with 900 COVID-19 patients shows success of a new patent-protected compound from the Cluster of Excellence PMI in Kiel (Germany). / An innovative nutritional ...